Molecular imaging in tumor angiogenesis and relevant drug research

	Molecular imaging in tumor angiogenesis and relevant drug research
	Tian, Jie; Ma, Xibo; Yang, Xin; Qin, Chenghu
发表期刊	International Journal of Biomedical Imaging
	2011
卷号	2011 期号:2011 页码:-
摘要	Molecular imaging, including fluorescence imaging (FMI), bioluminescence imaging (BLI), positron emission tomography (PET), single-photon emission-computed tomography (SPECT), and computed tomography (CT), has a pivotal role in the process of tumor and relevant drug research. CT, especially Micro-CT, can provide the anatomic information for a region of interest (ROI); PET and SPECT can provide functional information for the ROI. BLI and FMI can provide optical information for an ROI. Tumor angiogenesis and relevant drug development is a lengthy, high-risk, and costly process, in which a novel drug needs about 10–15 years of testing to obtain Federal Drug Association (FDA) approval. Molecular imaging can enhance the development process by understanding the tumor mechanisms and drug activity. In this paper, we focus on tumor angiogenesis, and we review the characteristics of molecular imaging modalities and their applications in tumor angiogenesis and relevant drug research.
关键词	Tumor Angiogenesis
收录类别	EI
WOS记录号	WOS:20113714332030
引用统计
文献类型	期刊论文
条目标识符	http://ir.ia.ac.cn/handle/173211/3890
专题	中国科学院分子影像重点实验室
通讯作者	Tian, Jie
推荐引用方式 GB/T 7714	Tian, Jie,Ma, Xibo,Yang, Xin,et al. Molecular imaging in tumor angiogenesis and relevant drug research[J]. International Journal of Biomedical Imaging,2011,2011(2011):-.
APA	Tian, Jie,Ma, Xibo,Yang, Xin,&Qin, Chenghu.(2011).Molecular imaging in tumor angiogenesis and relevant drug research.International Journal of Biomedical Imaging,2011(2011),-.
MLA	Tian, Jie,et al."Molecular imaging in tumor angiogenesis and relevant drug research".International Journal of Biomedical Imaging 2011.2011(2011):-.

条目包含的文件		下载所有文件
文件名称/大小	文献类型	版本类型	开放类型	使用许可
370701.pdf（2557KB）	期刊论文	作者接受稿	开放获取	CC BY-NC-SA	浏览下载